# Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance Therapy

> **NCT03920813** · PHASE4 · UNKNOWN · sponsor: **Shandong University** · enrollment: 500 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Mercaptopurine

## Key facts

- **NCT ID:** NCT03920813
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2019-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03920813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03920813, "Determinants of Mercaptopurine Toxicity in Paediatric Acute Lymphoblastic Leukemia Maintenance Therapy". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT03920813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*